Archive

In support of the first interactive national repository of information on COVID-19 test research

toward the costs of producing and disseminating a virtual learning series and case study on the eradication of smallpox and its relevance to today’s global health problems

in support of establishing regional genomic surveillance networks that seek to increase the volume and diversity of samples sequenced such that genomic epidemiology can better inform medical and public health counter measures in the Southeastern U.S.

for use by its LSU Health Sciences Center Shreveport, in support of establishing regional genomic surveillance networks that seek to increase the volume and diversity of samples sequenced such that genomic epidemiology can better inform medical and public health counter measures

in support of establishing regional genomic surveillance networks that seek to increase the volume and diversity of samples sequenced such that genomic epidemiology can better inform medical and public health counter measures

foe use by its Centre for Epidemic Response and Innovation in support of improving sampling strategies, expanding sequencing, streamlining bioinformatics pipelines, and strengthening the scientific workforce towards more timely, representative, and reliable genomic surveillance in Sub-Saharan Africa

in support of accelerating the advancement of GISAID’s pathogen data sharing platform and tools utilizing data shared via GISAID and to further incentivize the global community of data producers to rapidly share data to enable real-time responses and the development of lifesaving countermeasures such as vaccines, drugs, therapeutics and tests to prevent, treat, detect, identify, and track pathogen threats.

in support of convening a consortium of research and clinical institutions to advance pathogen genomics to track SARS-CoV-2 variants and accelerate bioinformatics and global data sharing

in support of establishing regional genomic surveillance networks that seek to increase the volume and diversity of samples sequenced such that genomic epidemiology can better inform medical and public health counter measures in the Upper Midwest region of the U.S.

toward the costs of convening a workshop to examine the Food and Drug Administration’s use of the Emergency Use Authorization in order to ensure that it can become a more versatile public health and pandemic management vehicle